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Abstract
Purpose: Tumor microenvironments show remarkable tumor pO2 heterogeneity, as seen in prior
EPR pO2 images (EPROI). pO2 correlation with hypoxia response proteins is frustrated by large
rapid pO2 changes with position.
Procedures: To overcome this limitation, biopsies stereotactically located in the EPROI were
used to explore the relationship between vascular endothelial growth factor A (VEGF)
concentrations in living mouse tumors and the local EPROI pO2.
Results: Quantitative ELISA VEGF concentrations correlated (p=0.0068 to 0.019) with mean
pO2, median pO2, and the fraction of voxels in the biopsy volume with pO2 less than 3, 6, and
10 Torr.
Conclusions: This validates EPROI hypoxic fractions at the molecular level and provides a new
paradigm for the assessment of the relationship, in vivo, between hypoxia and hypoxia response
proteins. When translated to human subjects, this will enhance understanding of human tumor
pathophysiology and cancer response to therapy.
Key words: EPR, EPR oxygen images, Tumor oxygenation, VEGF, Image-guided therapy,
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Introduction
T umor microenvironment is a major determinant oftumor growth and development [1]. Aspects of the
microenvironment, particularly pO2, modulate transforma-
tion and tumor growth as the immediate source of the
conditions to which malignant cells respond [2]. Tumor
microenvironments determine delivery and modification of
therapeutic agents to cellular targets, often frustrating
beneficial effects from agents showing promise in cellular
experiments [3]. Microenvironmental lack of oxygen, hypo-
xia, determines radiation curability of tumors [4–9]. Changes
in these microenvironments reflect response to therapy and
may allow early prediction of ultimate therapeutic effect
[10]. However, many microenvironment measurements are
invasive opening questions as to their relevance to “real”
native animal environments [11–13].Correspondence to: Howard J. Halpern; e-mail: h-halpern@uchicago.edu
Vascular endothelial growth factor A (VEGF) is a crucial
protein generated in response to hypoxia and is the principal
stimulus for tumor blood vessel formation, angiogenesis [14,
15]. VEGF-stimulated angiogenesis insures the survival and
growth of human solid tumors beyond the short distance
over which oxygen may diffuse before it is consumed [16].
However, the quantitative relationship between pO2 and
VEGF production in native environments remain substan-
tially unexplored. Electron paramagnetic resonance (EPR)
images (EPRI) give spatial distributions of quantitative
tumor oxygenation (EPROI) in native, “real” unperturbed
conditions using injected non-toxic small molecule pO2
reporters of the environment [17–21]. The excitation
frequencies at which images are obtained are those of newer
human magnetic resonance imaging (MRI), with magnetic
fields that are less than 10 millitesla, 1/658 that of MRI.
Spectroscopic imaging allows direct interrogation of the
highly specific and sensitive EPR spectral response of the
reporter molecules to various aspects of tissue and tumor
microenvironment such as pO2 [22]. But a major difficulty
in correlating pO2 with cell and tissue hypoxic response has
been the rapid variation of pO2 with location. Comparisons
of wildly fluctuating pO2 values with unlocated biopsies blur
any real correlation with the VEGF hypoxia protein and
prevent understanding of this varying microenvironment. In
principle, local oxygen measurements with a polarographic
electrode could be stereotactically registered with a subse-
quent stereotactically guided biopsy to try to relate small
regions with high and low pO2 with hypoxia protein
production. However, we are unaware of such registered
measurements. Moreover, the electrode might perturb the
environment sufficiently to create significant artifact.
Key to probing this relationship between the extent of
hypoxia and the amount of VEGF production is co-location
of the biopsy with the location of the pO2 values in the
oxygen image. EPR oxygen images have spatial resolution
of approximately 1 mm with a pO2 resolution of approx-
imately 1–3 mmHg (torr) [23]. We previously demonstrated
that rapid spatial variation of tumor pO2 seen in EPROI with
gradients of 50 Torr/mm correlated with Oxylite™ measure-
ments and gradients co-localized with the image pO2 voxels.
To do this, we designed and built a sterotactic delivery
system to bring the Oxylite™ tip to the same location in the
tumor as the image voxel [19]. For the work described here,
we modified this device to accept an 11-gauge bone biopsy
needle. This allowed us to obtain biopsies whose contents
could be registered or co-located with the proper EPR
oxygen image voxels. Using this technique, we quantified
for the first time in a native state, the in vivo relationship
between EPROI oxygen concentrations and the VEGF
hypoxia protein response of cells in a tumor. This technol-
ogy opens the study of the relationship between in vivo
EPROI and a variety of hypoxia proteins. A biopsy localized
in a microenvironment image, e.g., a pO2 image, is a
precondition to fully understanding the nuanced, quantified
interplay between all aspects of the tumor microenvironment
and its effect on tumor growth in situ in animals. These pO2
images will be eventually obtained in humans to guide
individual human tumor therapy. It is crucial to use this
stereotactic biopsy technique to understand the local
response of animal tumors to oxygen specifically where it
is occurring.
Materials and Methods
Short Description of the Basic Stereotactic
Location Method
The basic observation predicating this method development is that
oxygen physiology varies rapidly with position as shown below in
EPR oxygen images. Thus physiologic correlates need to be
obtained at the same position as the voxels in the EPROI. We
previously dealt with a similar problem in validating the EPROI. A
stereotactic system was developed to launch an Oxylite™ fiberoptic
oxymetric probe into animal tissue in the imager so that the oxygen
sensitive tip of the Oxylite™ could be located in the image and
registered with the corresponding image voxels. This validated the
pO2 values measured in each EPROI voxel [19]. For the measure-
ments described here, biopsies, from which the quantitative levels
of a hypoxia response protein were derived, needed to be located in
the EPROI. The Oxylite™ was replaced with a stainless steel 11-
gauge bone biopsy needle with an inner diameter of 1.8 mm.
Biopsies were obtained from tumor volumes that contained ~200
image voxels. The substantially larger diameter of the needle
stiffened it relative to the 200 μm glass fiber diameter of the
Oxylite™ eliminating concern about the needle bending creating
location uncertainty. Moreover, the larger size of the biopsy
reduced sensitivity to slight variations (order, 0.5 mm) in relative
location of biopsy and image co-location. By recording the
stereotactic coordinates of the needle tip when it touched a known
location in the image coordinate system, the locations of the biopsy
and those of the image could be related or registered. This provided a
means for imaging the animal tissue and tumor pO2 in a native
condition which is violated only at biopsy, which was obtained in a
matter of minutes. Thus, pO2 data was obtained with minimal
perturbation of the animal, avoiding artifact and distortion of the data.
Spin Probe
EPRI uses a specific spin probe injected into the animal specimen
to report specific aspects of the tissue environment, in this case and
for this probe, oxygen [24]. The spin probe was OX063 trityl
radical (methyl-ris[8-carboxy-2,2,6,6-tetrakis[(2-hydroxyethyl]
benzo[1,2-d:4,5-d′]bis[1,3]dithiol-4-yl]-, trisodium salt, MW
1427), a kind gift from GE Healthcare, London, GB. A single
inhomogeneously broadened spectral line with a peak-to peak line
width of 16.5 μT and a spin packet linewidth of 1.6 μT in hypoxic
solutions is further broadened in the presence of oxygen by
0.054 μT/Torr. Other free paramagnetic species, self-broadening,
viscosity broadening, and power saturation can broaden the line as
well but these effects are small and are accounted for via an oxygen
calibration [18]. A concentration of 0.25 g/mL of OX063 was
achieved by dissolving the intensely green powder in distilled
water. Any residual particles were cleared using a 40 μm filter. We
injected a 0.2 mL of this solution (1.4 mmol/kg body weight)
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intravenously into a mouse weighing 25 g. This corresponds to ~1/
5 of the LD50 for the spin probe [25]. The spin probe is a triacid
salt. The solution was, therefore, slightly hypertonic and was well
tolerated. The tumor half-life of the spin probe of ~30 min was
much longer than that in other tissues.
Animal Preparation
Seven tumors were used for the comparison of EPRI with VEGF
concentrations. FSa cells were a kind gift from Kathy Mason, M.
D. Anderson Hospital, Houston, TX. Cells were injected intra-
muscularly into the mid distal hind legs of 6–8 week old C3H/
HeN/Hsd (Harlan Sprague Dawley, Indianapolis, IN) female mice.
Tumors were grown to 9 to 11 mm diameter in 10 days. Animals
were both immobilized and anesthetized for both biopsy and
EPROI measurements, minimizing animal movement during the
procedures. Gas anesthesia with 1-2% isofluorane mixed with
medical grade air was adjusted to regularize breathing and prevent
animal motion during the imaging and the biopsy procedure.
Respiration frequency and depth were monitored continuously. A
24 G Angiocath was used to cannulate the mouse tail. The leg/
tumor was immobilized with soft elastic vinyl polysiloxane dental
mold material (GC America Inc, Alsip, IL) as shown in Fig. 1. A
Physitemp (Clifton, NJ) digital needle probe thermometer was
used to measure the skin temperature. The skin temperature was
maintained at 33.5°C with opposed heating lamps. The trityl spin
probe accumulates rapidly in the mouse bladder and creates a
changing source of confounding signal and consequent artifact.
Using a double lumen urethral catheter and Harvard 22 syringe
pump (Harvard Apparatus, Holliston, MA), we flushed the
bladder at 15 mL/h to eliminate this [26].
The beginning of imaging to the end of the biopsy procedure
was approximately 2 h. The complete experiment, including the
animal preparation (approximately 45 min), could be up to 3 h
long. We carefully maintained a steady level of anesthesia and
monitored the breathing rate and temperature during the experiment
to ensure that the oxygenation level of the tissues was similar for
EPRI and biopsy.
All animal experiments were performed according to the US
Public Health Service “Policy on Humane Care and Use of
Laboratory Animals” and the protocols were approved by the
University of Chicago Institutional Animal Care and Use Commit-
tee (ACUP No 69681). The University of Chicago Animal
Resources Center is an AALAC approved animal care facility.
EPR Imaging
4D EPR images were obtained using a spectroscopic imager with
an air-core magnet and Anderson type gradient coils [27] operating
at 250 MHz and 9 mT as described previously [28]. The Zeeman
field was modulated at 4.98 KHz with over-modulation. The peak-
to-peak linewidth of the OX063 trityl is 16.0 μT. We used an
accurate line shape simulation that allows operation with high
modulation amplitude (17 μT) to increase signal-to-noise ratio
(SNR) in images without sacrifice in the determination of the
intrinsic or spin packet line width [29, 30]. The quality factor (Q) of
the resonator was approximately 280 without the tumor and 200
with the tumor installed. The power delivered to the resonator was
25 μW and well below the saturation level (200 μW).
EPROIs were acquired and reconstructed using a 4D tomographic
spectroscopic imaging technique. This involves the acquisition of
spectra with fixed gradients, referred to as projections. Each projection
involved the acquisition of 256 field points scaled to uniformly
populate the field interval determined by the gradient as has been
described previously [23]. The projections were subjected to a
Gaussian filter whose width was four points and then subsampled to
64 points. A field of view of 3 cmwas used. This determined our voxel
size to be (3√2 cm/64) or 0.66 mm in the spatial direction. This voxel
size determination has been discussed extensively elsewhere [18, 28].
Projections were obtained with 14 gradient amplitudes and a
subset of ten polar and ten azimuthal direction angles chosen to
sample the solid angle uniformly [31]. An image required
approximately 45 min. The low SNR at higher gradient projections
were partially compensated for by signal averaging of multiple field
sweeps, up to ten averages for the highest gradient. Each sweep
was obtained with 256 field points with acquisition time of 3 ms/
point, 3 ms time constant, and 12-dB/octave filter using a SR830
lock-in amplifier (Stanford Research Systems, Sunnyvale, CA).
The spatial field of view (FOV) and the spectral FOV were 3 cm
and 0.1 mT. Spectroscopic image reconstruction used filtered back-
projection as described previously [18, 28, 32]. All image voxels
with spin probe amplitude less than or equal to 15% of the
maximum spectral amplitude in the image were discarded. This
15% threshold was used to avoid fitting voxels with no signal or
very poor signal. Small areas within several images had maximum
intensities that did not survive this threshold. The oxygen values for
these areas were discarded. The oxygen maps reconstructed and
fitted from the images have pO2 resolution of ~3 Torr and a
measured spatial resolution of ~1 mm. Oxygen partial pressure
resolution is limited by the accuracy of the spin probe spectral
linewidth measurement. The actual source of the uncertainty is a
complicated function of signal noise, sampling frequency and the
various forms of data filtering used in the reconstruction. In
Fig. 1. Experimental setup. FSa tumor in the resonator,
immobilized with vinyl polysiloxane (blue). Stereotactic
device was used to register the location of the 11-gauge
bone biopsy needle in the tumor volume.
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homogenous phantom imaging experiments we have found that
linewidth scatter is 0.16 μT, which is equivalent to 3 Torr via the
oxygen vs linewidth calibration which is discussed in ref. [18].
Each image has a voxel size of (0.66 mm)3. The basic spectral
response to oxygen is the broadening of the line in response to the
collision with local molecular oxygen. [33] Thus, to first order the
technique is insensitive to the amount of spin probe present, which
is proportional to the amplitude or height of the signal. As have
others, minimal self-broadening corrections were used for low (less
than 1 mM concentrations) of spin probe [30].
Selecting the Location of the Biopsy Needle
in the Oxygen Image
Immediately after the EPR imaging, the pO2 image of the leg with
the tumor was reconstructed, and pO2 values from all the voxels
were printed out in a series of tracks, with a precise location of the
track in the tumor. Biopsy position was picked, essentially on the
fly, as one that has predominantly low values (≤20 Torr) at one end,
and high values (≥20 Torr) at the other end of the track along the y-
axis, the axial direction of the resonator. Fig. 2 shows an example
of the voxels in the EPROI chosen for analysis corresponding to the
biopsy in the tumor. Fig. 2 represents the voxels from a sagital and a
coronal view of a typical EPROI. The voxels shown inside and
including the bright red square were selected for analysis. The figure
shows the central track corresponding to the center of the needle plus
andminus two voxels transverse to the track. This track size was chosen
based on the inner diameter of the needle (1.8 mm) and the resolution of
the measurement (~1 mm). Given the voxel size of 0.67 mm, this is best
approximated by a transverse square of 5×5 voxels.
Biopsy Technique
While the animal was still in the EPR imager and under anesthesia,
the sterotactic positioning device for location of the biopsy needle
was rapidly and easily installed (Fig. 1). The chosen position of the
biopsy was marked on the skin of the tumor. Then the skin was cut
with small surgical scissors. Biopsies were obtained with an 11-
gauge (1.8 mm inner diameter) bone biopsy needle (Becton
Dickinson, Franklin Lakes, NJ). The biopsy needle was inserted
into the puncture wound and then fully through the tumor to
approximately 10-12 mm depth. The needle was rotated carefully to
isolate the biopsy from the tumor tissue and then withdrawn slowly,
with a small suction applied using a syringe. Depending on the tumor
size, the length of the biopsy was between 7 and 12 mm. These 1.8-
mm diameter tubes of tissue passed through both well oxygenated and
hypoxic regions. Based on the information from EPROI, biopsy
obtained was then divided longitudinally into hypoxic and oxic
samples.We obtained a total of 17 samples from seven tumors imaged.
VEGF Determination in Tumor Biopsy
Biopsies were weighed, homogenized, and transferred into a lysis
buffer containing 50 mM Tris pH 7.4, 3 mM EDTA, 20 mM β-
glycerophosphate, and proteases inhibitors cocktail (chemicals were
from either Fisher Scientific, Pittsburgh, PA, USA, or Sigma
Aldrich, St. Louis, MO, USA). After three freeze–thaw cycles to
break the cell membranes, the homogenates were centrifuged for
5 min at 5,000×g (Eppendorf centrifuge 5,415°C), 4°C and
supernatants were collected. The total protein concentrations were
determined using Bradford assay (Bio–Rad Laboratories, Hercules,
CA, USA).
VEGF protein concentration was determined using the ELISA
Quantikine Mouse VEGF Immunoassay (R & D systems, Cat. no.
MMV00, Minneapolis, MI, USA). No significant cross-reactivity
tested for several other factors, including other members in the
VEGF family, was observed. The intra-assay precision is 4.3–8.2%,
average percent recovery is 91% in mouse tissue homogenates, and
the technique is sensitive to less than 3.0 pg/mL. The amount of the
VEGF in the biopsy was expressed as pg of VEGF protein per mg
of the total protein in the biopsy.
Statistical Analysis
The biopsy volume, projected into the EPROI as shown in Fig. 2,
selected an average of 100 voxels. We accepted voxels surrounding
the inner volume of the biopsy needle in order to account for the
cubic sampling and the 1 mm resolution of the EPROI. This
Fig. 2. Location of voxels in axial and sagittal slices from 3D
EPR oxygen image, corresponding to the location of a
biopsy, which is outlined in red. The pO2 for each voxel is
indicated in torr (mmHg) by the color bar to the right of the
image.
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number allowed us to calculate descriptive statistics from the
projected volume in the EPROI including median pO2, mean pO2,
fraction of voxels less than 10, 6, and 3 Torr. The fraction of voxels
less than 10, 6, and 3 Torr is referred to, respectively, as HF10, HF6,
and HF3. Errors in VEGF concentration were determined from
three separate VEGF concentration sub-samples from each sample.
Uncertainties in the hypoxic fraction were calculated by computing
the uncertainty in a fraction propagated from uncertainties in the
numerator and denominator. These uncertainties were estimated
making the assumption for each number a Poisson distribution with
standard error equal to the square root of the numbers of voxels in
each group, e.g., HF10 error was calculated as:
HF10 ¼ HF10
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
NHv2
NHv2
þ Nv
2
Nv2
r
;
where NHv is the number of hypoxic voxels, and Nv is the total
number of voxels in the biopsy.
The Pearson product moment coefficient of the correlation
between oxygen statistics from EPROI and VEGF mass per mass of
sample protein R, and p, the significance of each correlation were
calculated using STATA software.
Results
EPR Oxygen Images Show Steep Gradients
in Oxygen Tension in the Tumor Over Distances
of 1 mm
Fig. 1 shows an FSa fibrosarcoma in the leg of a C3H mouse
immobilized in the resonator/sample holder of the EPR
oxygen imager. The 11 gauge biopsy needle is fixed in the
stereotactic needle holder which is attached to the imager,
locating the needle tip in the image coordinate system of the
imager. The biopsy needle is seen extending into the tumor.
Fig. 2 shows the oxygen image obtained from the FSa
fibrosarcoma. The colorbar in Fig. 2 correlates color with
oxygen partial pressures in each (0.66 mm)3 voxel. The
image shows axial and sagittal planar pO2 slices of the
tumor. Oxygen gradients of 40 Torr/mm are seen in the
image. These gradients are typical of most tumor EPROI.
The red box represents the boundaries of the biopsy voxels
contained in the needle shown in Fig. 1. The last 5.3 mm of
the needle provide the material from which the VEGF was
sampled in this particular measurement, shown in the red
box in Fig. 2a, b. From the pO2 voxels within and including
the box, EPROI statistical summaries of the roughly 200
pO2 voxels were obtained including mean pO2, median pO2,
and fraction of the voxels with pO2 less than 3, 6, and
10 Torr. These fractions of the total number of voxels with
pO2 less than a certain value are EPROI hypoxic fractions,
referred to as HF3, HF6, and HF10.
All pO2 Statistical Summaries from the pO2 Image
of the Biopsies Correlate Significantly with VEGF
Protein Content in the Biopsy
The first column of Table 1 shows the Pearson product
moment correlations (R value) for each of the biopsy pO2
voxel statistical summaries and the second column shows their
significance. All of the correlations have p≤0.05. The p values
of the hypoxic fractions are approximately a factor of two
smaller than those of the median and mean pO2 indicating that
the significance of the hypoxic fractions are twice that of the
mean and median pO2. R values rather than R
2 are used
because it is a measure of the part of the linear regression line
due to true variation and not due to random variation. Fig. 3
shows a plot of the VEGF concentrations in each biopsy vs the
HF10. The linear regression is also shown, corresponding to the
stated R of 0.63. As can be seen in Fig. 2, within a biopsy there
are steep gradients in pO2. This weakens the correlation
between mean or median pO2 and favors the hypoxic voxel
fractions. This is consistent with the smaller p values and
improved significance of the hypoxic fraction statistics relative
to overall voxel pO2 average and median statistics.
Discussion
In prior work, in vitro measurements of human MX-1 breast
cancer cells showed a quantitative relationship between
Table 1. Correlations and their significance between VEGF concentrations
and various hypoxic fractions and the mean and median oxygen pO2 in the
biopsy specimen determined from the voxels of the biopsy track cast into
the EPR oxygen image with different margins
Oxygenation statistic R (n=17) p (n=17)
Mean pO2 0.56 0.0189
Median pO2 0.59 0.0122
HF10 0.63 0.0068
HF6 0.62 0.0081
HF3 0.58 0.0143
R was chosen over R2 because it represents the fraction of variation not due
to random fluctuation
Fig. 3. Correlation between hypoxia and VEGF content.
Fraction of voxels in the biopsy with pO2 less than 10 Torr,
HF10 from the EPR oxygen image vs VEGF concentration in
picograms per microgram of total protein. For method of
error calculation, see “Material and Methods”, “Statistical
Analysis”.
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VEGF levels and pO2 in the atmosphere in which cells were
grown [12]. Ambient pO2 levels between 3% and 0.1% led
to several fold increase in the amount of VEGF mRNA, as
well as the increased level of the protein itself, with half-
maximum levels at 1.5–3%, i.e., 10 and 20 Torr of oxygen
[11]. Inspiratory hypoxia (at 10% O2), a qualitative measure
of tumor hypoxia, increased the VEGF levels in MX-1
tumors grown in nude mice [11]. Using a cranial window
chamber, Fukumura et al. [13] orthotopically grew human
gliomas in SCID mice. Quantitative pO2 images locally
correlated with VEGF expression as seen using a coupled
green fluorescent protein. These studies showed the spatial
registration of oxygen and VEGF induction as well as
quantified and localized pO2 correlation with VEGF expres-
sion. This was accomplished at the cost of an invasive and
artificial experimental paradigm, and limiting sensitivity to
superficial structures near the window.
The data presented here represent an insight into the
quantitative relationship between pO2 and the production
of VEGF with the pO2 information obtained under native
in vivo conditions. Prior work investigating the parameter
that optimally predicts of the effect of pO2 on the
outcome of tumor control with radiation choose a 10 Torr
measure of in vivo tissue hypoxia. This includes the
pioneering work of Kolstad in cervical malignancies [34]
and Gatenby [35] looking at radiation control of lymph
nodes and that of Hockel et al. in uterine cancer and
Brizel et al. in soft sarcoma [8, 36]. Other authors found
HF2.5 to be a prognostic factor in head and neck cancers
[37]. In vitro measurements show the pO2 for half the
oxygen enhancement is consistently closer to 3 Torr. Our
own laboratory has shown that the optimal EPROI pO2
predictor of tumor control by radiation, in addition to
radiation dose is the HF10. These EPROI were obtained in
native conditions as those described here. They also show
a high significance of the correlation with the HF3 but to
a slightly smaller degree in correlation magnitude and
significance than the HF10 [38]. It is to be expected that
different pO2 measurement techniques measure different
aspects of local oxygen and will highlight somewhat
different pO2 values [39]. A review by Peter Vaupel, et
al., also demonstrates the strong correlation between
tumor cure and hypoxic fractions at threshold values of
from 2.5 to 10 Torr [40].
Since normoxic VEGF protein half-life is 15–20 min and
the half-life of VEGF mRNA is 30 min [41], while hypoxic
VEGF mRNA half-life increases to 6–8 h, VEGF protein
levels appear to be more sensitive to chronic hypoxia [41–
43] rather than transient hypoxia lasting only a few minutes
[44–47]. The tissue level of VEGF is an equilibrium
between VEGF production and secretion and conveyance
away through the circulation, a chronic condition. EPR
oxygen images are obtained in approximately 45 min. It is
therefore also more sensitive to and diagnostic of chronic
hypoxia. Thus, VEGF concentration and EPROI hypoxia are
responding to the same type of microenvironmental hypoxia.
Conclusions
EPR imaging of pO2 and registered localized interrogation
of the hypoxic signaling response is a new paradigm for
biologic measurement. EPR oxygen images provide infor-
mation that is spatially localized. The spatial differentiation
allows spatial patterns to be discerned, characterizing the
individual subject [38]. On the other hand, registration of the
oxygen images with localized biopsy, shown for the first
time in this work, allows multiple experiments to be
obtained from the same location in an animal tumor to
determine how the oxygen tension is related, in vivo, with
the quantified production of a protein synthesis response to
quantified low oxygen tensions. As images improve in
quality, simple linear correlation between pO2 hypoxic
fraction and VEGF concentration will give way to probing
of pO2 thresholds for VEGF signaling or other, non-linear
behavior that is more likely to characterize individual
response both to hypoxia and to therapy. Because EPROI
show individualized patterns of hypoxia, they will allow
individualized delivery of cancer therapy or individualized
risk assessment for myocardial infarction, stroke, or periph-
eral vascular disease. For all of these diseases, response to
therapy can be individualized using EPROI.
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